Sandrine Miller-Montgomery, Pharm.D., Ph.D. is the Co-Founder, President and CEO of Micronoma, the first cancer-detection company using liquid biopsy technology to detect and predict cancer at an early stage of the disease by analyzing the microbial signal with clinical-grade accuracy. Prior to this, she was executive director of UC San Diego’s Center for Microbiome Innovation that she co-led with Dr. Rob Knight. Before her time in academia, she had worked in large biotech and multinational companies as well as start-ups where she excelled at preparing companies for successful exits as shown by her work at Helixis, acquired by Illumina, and MO BIO Labs acquired by QIAGEN.